An Exact Formula for Estimation of Age-Specific Sensitivity for Screening Tests

Ning Jia, Sandra J. Lee

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, USA.

DOI: 10.4236/am.2014.517265                

Abstract

There has been a growing interest in screening programs designed to detect chronic progressive cancers in the asymptomatic stage, with the expectation that early detection will result in a better prognosis. One key element of early detection programs is a screening test. An accurate screening test is more effective in finding cases with early-stage diseases. Sensitivity, the conditional probability of getting a positive test result when one truly has a disease, represents one measure of accuracy for a screening test. Since the true disease status is unknown, it is not straightforward to estimate the sensitivity directly from observed data. Furthermore, the sensitivity is associated with other parameters related to the disease progression. This feature introduces additional numerical complexity and limitations, especially when the sensitivity depends on age. In this paper, we propose a new approach that, through combinatorial manipulation of probability statements, formulates the age-dependent sensitivity. This formulation has an exact and simple expression and can be estimated based on directly observable probabilities. This approach also helps evaluate other parameters associated with the natural history of disease more accurately. The proposed method was applied to estimate the mammography sensitivity for breast cancer using the data from the Health Insurance Plan trial.

Keywords

Early Detection of Disease, Screening Test, Sensitivity

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Shapiro, S., Venet, W., Strax, P., et al. (1988) Periodic Screening for Breast Cancer: The Health Insurance Plan Project and Its Sequelae, 1963-1986. The Johns Hopkins University Press, Baltimore.
[2]	Tabar, L., Gunnar, F., Duffy, S.W., et al. (1992) Update of the Swedish Two-County Program of Mammographic Screening for Breast Cancer. Radiologic Clinics of North America, 30, 187-210.
[3]	Andersson, I., Aspegren, K., Janzon, L., et al. (1988) Mammographic Screening and Mortality from Breast Cancer: The Malmo, Mammographic Screening Trial. British Medical Journal, 297, 943-948. http://dx.doi.org/10.1136/bmj.297.6654.943
[4]	Frisell, J., Glas, U., Hellstrom, L., et al. (1986) Randomized Mammographic Screening for Breast Cancer in Stockholm. Breast Cancer Research and Treatment, 8, 45-54. http://dx.doi.org/10.1007/BF01805924
[5]	Bjurstam, N., Bjorneld, L., Duffy, S.W., et al. (1997) The Gothenburg Breast Screening Trial: First Results on Mortality, Incidence, and Mode of Detection for Women Ages 39 - 49 Years at Randomization. Cancer, 80, 2091-2099. http://dx.doi.org/10.1002/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.0.CO;2-#
[6]	Roberts, M.M., Alexander, F.E., Anderson, T.J., et al. (1990) Edinburgh Trial of Screening for Breast Cancer: Mortality at Seven Years. Lancet, 335, 241-246. http://dx.doi.org/10.1016/0140-6736(90)90066-E
[7]	Miller, A.B., Baines, C.J., To, T., et al. (1992) Canadian National Breast Screening Study 1: Breast Cancer Detection and Death Rates among Women Aged 40 to 49 Years. Canadian Medical Association Journal, 147, 1459-1476.
[8]	Duffy, S.W., Chen, H., Tabar, L. and Day, N. (1995) Estimation of Mean Sojourn Time in Breast Cancer Screening Using a Markov Chain Model of Both Entry to and Exit from the Preclinical Detectable Phase. Statistics in Medicine, 14, 1531-1553. http://dx.doi.org/10.1002/sim.4780141404
[9]	Paci, E. and Duffy, S.W. (1991) Modeling the Analysis of Breast Cancer Screening Programmes: Sensitivity, Lead Time and Predictive Value in the Florence District Programmes (1975-1986). International Journal of Cancer, 20, 852-858.
[10]	Shen, Y. and Zelen, M. (1999) Parametric Estimation Procedures for Screening Programmes: Stable and Non-Stable Disease Models for Multimodality Case Finding. Biometrika, 86, 503-515. http://dx.doi.org/10.1093/biomet/86.3.503
[11]	Shen, Y. and Zelen, M. (2001) Screening Sensitivity and Sojourn Time from Breast Cancer Early Detection Trials: Mammograms and Physical Examinations. Journal of Clinical Oncology, 19, 3496-3499.
[12]	Tabar, L., Fagerberg, G., Chen, H., et al. (1995) Efficacy of Breast Cancer Screening by Age. Cancer, 75, 2507-2517. http://dx.doi.org/10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H
[13]	Zelen, M. (1993) Optimal Scheduling of Examinations for the Early Detection of Disease. Biometrika, 80, 279-293. http://dx.doi.org/10.1093/biomet/80.2.279
[14]	Stanley, R.P. (1999) Enumerative Combinatorics, Vol. 1. Cambridge University Press, Cambridge. http://dx.doi.org/10.1017/CBO9780511609589